Incidencia, factores relacionados con la presentación, evolución y mortalidad de la acidosis láctica asociada a metformina en el área sanitaria de un hospital de tercer nivel

Peña Porta, José María; Villafuerte Ledesma, Hilda Mercedes; Vera Floristán, Carmen Vicente de; Ferrer Dufol, Ana; Salvador Gómez, Tránsito; Álvarez Lipe, Rafael.
Nefrología (Madrid) ; 39(1): 35-43, ene.-feb. 2019. graf, tab
Artículo en Español | IBECS (España) | ID: ibc-181907

Documentos relacionados

  1. Incidence, factors related to presentation, course and mortality of metformin-associated lactic acidosis in the healthcare area of a tertiary hospital.
  2. Metformin-Associated Lactic Acidosis Undergoing Renal Replacement Therapy in Intensive Care Units: A Five-Million Population-Based Study in the North-West of Italy.
  3. Continuous use of metformin in patients receiving contrast medium: what is the evidence? A systematic review and meta-analysis.
  4. High risk and low prevalence diseases: Metformin toxicities.
  5. Metformin associated lactic acidosis: a case series of 28 patients treated with sustained low-efficiency dialysis (SLED) and long-term follow-up.
  6. Diabetes, metformin and lactic acidosis.
  7. Renal Complications after Percutaneous Coronary Interventions on Concurrent Metformin Therapy: A Systematic Review with Meta-Analysis.
  8. Ventilator Management in Metformin-Associated Lactic Acidosis: A Case Report.
  9. Extracorporeal treatment of metforminassociated lactic acidosis in clinical practice: a retrospective cohort study.
  10. Metformin's Role in Hyperlactatemia and Lactic Acidosis in ICU Patients: A Systematic Review.